This new 247-page report from VPGMarketResearch provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2015-2019 Future Horizons and Growth Strategies in the Italian Therapeutic Drug Monitoring (TDM) Market is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 247 pages and 17 tables
SIMILAR MARKET STUDIES
Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability. This new report from VPG provides strategic assessment of A-B InBevs technological know-how, marketing tactics and strategic directions in the global food and beverage market. SECTION I: TECHNOLOGICAL KNOW-HOW SECTION II: MARKETING TACTICS SECTION III: STRATEGIC DIRECTION
June 2015 | $0 | View Details >>
This report is a crucial resource for industry executives and anyone looking to access key information about "Flying Brands Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
April 2014 | $99 | View Details >>
Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $3,950.“2014 Opportunities in the French Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the French cancer diagnostics markets; reviews current and ...
September 2013 | $4350 | View Details >>
2015 France Flow Cytometry Market: Reagent and Instrument Supplier Shares, Competitive Strategies, Country Test Volume and Sales Market Segment Forecasts, Innovative Technologies, Instrumentation Review
This report contains 146 pages, 15 tables and presents a comprehensive analysis of the French flow cytometry market, including:
October 2015 | $2500 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research